Evidence map›Paper›PMID 16365452›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2006

Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2.

Seung Hyun Han, Je Hak Kim, Ho Seong Seo, Michael H Martin, Gook-Hyun Chung, Suzanne M Michalek, Moon H Nahm

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Muramyl dipeptide potentiatesFrontiers in immunology · 2024
    Article
  3. Article
  4. Article
  5. Microorganisms · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The neural and vascular effects of killed Su-Streptococcus pyogenes (OK-432) in preterm fetal sheep.American journal of physiology. Regulatory, integrative and comparative physiology · 2010
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Seung Hyun HanDepartment of Pathology, University of Alabama at Birmingham, AL 35294, USA.
Je Hak Kim
Ho Seong Seo
Michael H Martin
Gook-Hyun Chung
Suzanne M Michalek
Moon H Nahm
University of Alabama at Birmingham · USInternational Vaccine Institute · KR

Funding

Impact of a new group 6 serotype on pneumococcal vaccinesR01AI031473 · NIAID · WASHINGTON UNIVERSITY · PI NAHM, MOON H. · 1991 to 2011
$1.7M
Pneumococcal capsule and host innate immunityR56AI031473 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAHM, MOON H. · 2012 to 2012
$366k
NIAID NIH HHS AI-31473NIAID NIH HHS N01 AI030021NIAID NIH HHS R01 AI031473NIAID NIH HHS R56 AI031473
6 · The paper itself

Abstract

NO production by macrophages in response to lipoteichoic acid (LTA) and a synthetic lipopeptide (Pam3CSK4) was investigated. LTA and Pam3CSK4 induced the production of both TNF-alpha and NO. Inhibitors of platelet-activating factor receptor (PAFR) blocked LTA- or Pam3CSK4-induced production of NO but not TNF-alpha. Jak2 tyrosine kinase inhibition blocked LTA-induced production of NO but not TNF-alpha. PAFR inhibition blocked phosphorylation of Jak2 and STAT1, a key factor for expressing inducible NO synthase. In addition, LTA did not induce IFN-beta expression, and p38 mitogen-activated protein serine kinase was necessary for LTA-induced NO production but not for TNF-alpha production. These findings suggest that Gram-positive bacteria induce NO production using a PAFR signaling pathway to activate STAT1 via Jak2. This PAFR/Jak2/STAT1 signaling pathway resembles the IFN-beta, type I IFNR/Jak/STAT1 pathway described for LPS. Consequently, Gram-positive and Gram-negative bacteria appear to have different but analogous mechanisms for NO production.

Indexed as

AnimalsEnzyme InhibitorsGram-Positive Bacterial InfectionsJanus Kinase 2LipopolysaccharidesMacrophagesMiceNitric OxidePeptidesPlatelet Membrane GlycoproteinsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, G-Protein-CoupledSTAT1 Transcription FactorTeichoic AcidsTumor Necrosis Factor-alphaEnzyme InhibitorsJak2 protein, mouseJanus Kinase 2Lipopolysaccharideslipoteichoic acidNitric OxidePeptidesplatelet activating factor receptorPlatelet Membrane GlycoproteinsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, G-Protein-CoupledSTAT1 Transcription FactorTeichoic AcidsTumor Necrosis Factor-alpha

Identifiers

PMID16365452
PMCPMC1364485
OpenAlexW2098136696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.